FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 524 participants.
Also called NCT06409364
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 524 participants
- Registry
-
NCT06409364
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Australia, New Zealand
- Registry status
- Recruiting
Technical summary
Registry record NCT06409364. Randomized; quadruple masking; primary purpose treatment. Start 2025-08-13 (actual); primary completion 2029-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage
- Acronym
- FLASH
- Condition
- Aneurysmal Subarachnoid Hemorrhage
- Intervention (Drug)
- Fludrocortisone
- Intervention (Drug)
- Placebo
- Lead sponsor
- The George Institute
Record details
- Record id
cardio:ct-nct06409364- Content hash
193e6d37303159cd044f04e1f3b2a0efcad7d5518344cbb233626e0043ebff68